Similar Search Results - EconBiz

An Exam to the System of European Patents, Public Health and the Biotech and Pharmaceutical Industry (Un Examen al Sistema de Patentes Europeo, Salud Pública y la Industria Farmacé...

Conde Gutierrez, Carlos Augusto - 2012

New technology, especially biotechnology and the creation of new medicines, represents a difficult legal task for the …

Persistent link: https://www.econbiz.de/10014189323

The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry

Banerjee, Tannista; Siebert, Ralph - 2014

Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...

Persistent link: https://www.econbiz.de/10010229875

How does basic research improve innovation performance in the world's major pharmaceutical firms?

Leten, Bart; Kelchtermans, Stijn; Belderbos, René - In: Industry and innovation 29 (2022) 3, pp. 396-424

Persistent link: https://www.econbiz.de/10013170079

Private and social returns to R&D : drug development and demographics

Benmelech, Efraim; Eberly, Janice C.; Papanikolaou, Dimitris - 2021

Persistent link: https://www.econbiz.de/10012511903

Access to medicines after TRIPS : is compulsory licensing an effective mechanism to lower drug prices? ; a review of the existing evidence

Urias, Eduardo; Ramani, Shyama V. - In: Journal of International Business Policy : JIBP 3 (2020) 4, pp. 367-384

Persistent link: https://www.econbiz.de/10012405471

Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly

Florio, Massimo - 2020

Persistent link: https://www.econbiz.de/10012242700

The impact of the entry of biosimilars : evidence from Europe

Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017

Persistent link: https://www.econbiz.de/10011708133

Many are called, few are chosen: the role of science in drug development decisions

Colen, Linde; Belderbos, René; Kelchtermans, Stijn; … - 2022

Persistent link: https://www.econbiz.de/10013541933

Industrial and organizational mutations in the medical and pharmaceutical sectors impulsed by open innovation during the pandemic

Adatto, Laurent; Aouinait, Camille; Son Thi Kim Le; … - In: Proceedings of the ENTRENOVA - ENTerprise REsearch … 8 (2022) 1, pp. 421-434

implementing Open Innovation in the pandemic context. These case studies concern the pharmaceutical firm Pfizer, the biotechnology …

Persistent link: https://www.econbiz.de/10014308369

The impact of patents on innovation, technology transfer and health : a pre- and post-TRIPs analysis of India's pharmaceutical industry

Horner, Rory - In: New political economy 19 (2014) 3, pp. 384-406

Persistent link: https://www.econbiz.de/10010419020

A service of the